65,054 Shares in Healthpeak Properties, Inc. (NYSE:DOC) Purchased by Romano Brothers AND Company

Romano Brothers AND Company purchased a new stake in Healthpeak Properties, Inc. (NYSE:DOC) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 65,054 shares of the real estate investment trust’s stock, valued at approximately $1,488,000.

A number of other hedge funds have also recently bought and sold shares of DOC. Rise Advisors LLC acquired a new position in shares of Healthpeak Properties in the 3rd quarter valued at approximately $29,000. Riverview Trust Co acquired a new stake in Healthpeak Properties in the third quarter valued at $35,000. UMB Bank n.a. bought a new position in Healthpeak Properties during the 3rd quarter valued at $40,000. Mather Group LLC. bought a new position in Healthpeak Properties during the 3rd quarter valued at $60,000. Finally, Livforsakringsbolaget Skandia Omsesidigt acquired a new position in Healthpeak Properties during the 3rd quarter worth $67,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Up 3.1 %

Healthpeak Properties stock opened at $23.12 on Thursday. The firm has a market capitalization of $16.27 billion, a P/E ratio of 66.06, a P/E/G ratio of 2.27 and a beta of 1.14. The company has a 50-day simple moving average of $22.21 and a 200-day simple moving average of $20.62. Healthpeak Properties, Inc. has a one year low of $15.24 and a one year high of $23.15. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.23). The firm had revenue of $695.50 million during the quarter, compared to the consensus estimate of $665.11 million. Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. Healthpeak Properties’s revenue for the quarter was up 27.5% on a year-over-year basis. During the same quarter last year, the company posted $0.45 EPS. As a group, equities analysts expect that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on DOC shares. Wells Fargo & Company restated an “equal weight” rating and issued a $23.00 target price (up previously from $22.00) on shares of Healthpeak Properties in a research note on Tuesday, October 1st. StockNews.com downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Saturday, October 19th. Citigroup lifted their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. Scotiabank upped their price target on Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a research report on Monday, September 9th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $20.00 to $28.00 in a report on Monday. One research analyst has rated the stock with a sell rating, five have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $22.62.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.